BIO-key International, Inc.

Total Valuation

BIO-key International, Inc. carries a market capitalization of 2.85M, placing it among publicly traded companies globally. Its enterprise value stands at 4.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Valuation Ratios

Enterprise Valuation

Financial Position

BIO-key International, Inc. maintains a current ratio of 2.41, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 33.47, indicating elevated leverage, while an interest coverage ratio of -46.33 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Stock Price Statistics

BIO-key International, Inc.'s stock has declined approximately -47.68293% over the past 52 weeks. The 50-day moving average sits at 5.29, while the 200-day moving average is 6.68.

Income Statement

Over the trailing twelve months, BIO-key International, Inc. generated 3.25M in revenue and converted that into -2.13M in net income, yielding earnings per share of -2.63. EBITDA reached -1.80M, while operating income came in at -1.98M.

Cash Flow

BIO-key International, Inc. produced -2.00M in operating cash flow over the past twelve months.

Margins

BIO-key International, Inc. operates with a gross margin of 74.68, reflecting its pricing power and cost economics. The operating margin of -60.86 and net profit margin of -65.68 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

BIO-key International, Inc.'s most recent stock split took place on April 30, 2026 with a 10:1 split ratio.

Scores

BIO-key International, Inc. posts an Altman Z-Score of -38.81, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.